Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Hufelandstr. 55, D-45147 Essen, Germany.
Complement Ther Med. 2013 Apr;21 Suppl 1:S34-47. doi: 10.1016/j.ctim.2012.01.001. Epub 2012 Feb 10.
Few data document the use of complementary and alternative medicine (CAM) in Europe, with even fewer investigating use by children.
A narrative, non-systematic review of CAM use in Europe was performed by combining data from published surveys with expert perspectives. Limitations created by a lack of representative studies, varying definitions of CAM use, and what qualifies as CAM in different countries was partially overcome by integrating local experts to summarise information available only in the national language and provide their perspectives about CAM availability, quality, use and popularity in their countries using a semi-structured questionnaire. Local and international published surveys were summarised, and the prevalence of CAM use was extrapolated.
Data from 20 European countries were available, representing 69% of the European population. Some data about CAM use by the general population were available for 90% of the examined countries, whereas peer-reviewed published surveys were available for only 60%. We extrapolated that 56% (range: 10-90%, adjusted for population size) of the European population in general had used CAM at least once in the past year. Surveys in CAM use by children were available for 55% of the investigated countries. The extrapolated prevalence of CAM use by children in Europe was 52% (range: 5-90%, adjusted for population size). Paediatric CAM experts reported an increasing awareness for and use of CAM in healthcare institutions.
This precursor for further surveys indicates that CAM appears to be popular not only among adults in Europe, but also for children. Development of a pan-European definition of CAM use and CAM therapies are required to achieve surveys comparable between European countries. Additionally, more research investigating the efficacy and potential adverse effects of CAM therapies is needed because of increasing CAM use by children in Europe.
关于欧洲补充和替代医学(CAM)的使用数据很少,针对儿童使用情况进行的研究则更少。
通过结合已发表调查数据和专家观点,对欧洲 CAM 使用情况进行了叙述性、非系统性综述。由于缺乏具有代表性的研究、CAM 使用定义的差异以及不同国家对 CAM 的定义不同,导致了一些局限性。通过整合当地专家来总结仅以本国语言提供的信息,并使用半结构化问卷提供他们对本国 CAM 可及性、质量、使用和流行程度的看法,部分克服了这些局限性。总结了 20 个欧洲国家的本地和国际已发表调查数据,并推断了 CAM 使用的流行率。
获得了 20 个欧洲国家的数据,占欧洲总人口的 69%。对于所检查的国家中的 90%,有一些关于一般人群 CAM 使用的数据,而只有 60%有同行评审的已发表调查。我们推断,欧洲一般人群中至少有 56%(范围:10-90%,根据人口规模调整)在过去一年中至少使用过一次 CAM。有 55%的调查涉及儿童 CAM 使用情况。欧洲儿童 CAM 使用的推断流行率为 52%(范围:5-90%,根据人口规模调整)。儿科 CAM 专家报告称,在医疗机构中对 CAM 的认识和使用不断增加。
作为进一步调查的前奏,这表明 CAM 在欧洲不仅在成年人中很受欢迎,而且在儿童中也很受欢迎。需要制定一个泛欧 CAM 使用和 CAM 疗法的定义,以实现欧洲国家之间可比的调查。此外,由于欧洲儿童对 CAM 的使用不断增加,需要更多研究来调查 CAM 疗法的疗效和潜在不良反应。